| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.49B | 44.28B | 38.96B | 35.82B | 44.20B | 33.57B |
| Gross Profit | 24.38B | 24.55B | 21.90B | 19.95B | 25.57B | 19.30B |
| EBITDA | 13.34B | 14.93B | 12.74B | 9.95B | 17.25B | 11.37B |
| Net Income | 9.92B | 5.54B | 10.14B | 7.23B | 12.94B | 9.04B |
Balance Sheet | ||||||
| Total Assets | 57.14B | 50.14B | 55.15B | 51.04B | 49.01B | 41.24B |
| Cash, Cash Equivalents and Short-Term Investments | 9.80B | 12.48B | 13.30B | 11.32B | 6.38B | 12.41B |
| Total Debt | 15.27B | 16.37B | 15.44B | 16.07B | 16.16B | 16.30B |
| Total Liabilities | 29.86B | 28.94B | 28.88B | 29.46B | 31.00B | 31.29B |
| Stockholders Equity | 27.28B | 21.21B | 26.27B | 21.58B | 18.01B | 9.95B |
Cash Flow | ||||||
| Free Cash Flow | 12.50B | 12.82B | 11.16B | 9.85B | 6.83B | 8.65B |
| Operating Cash Flow | 14.29B | 14.01B | 12.20B | 11.30B | 9.10B | 10.54B |
| Investing Cash Flow | -1.06B | -800.00M | -3.62B | 762.00M | -5.80B | -3.36B |
| Financing Cash Flow | -14.98B | -13.20B | -9.27B | -6.66B | -7.20B | -6.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $214.64B | 4.59 | 40.19% | 2.01% | 5.21% | -6.72% | |
79 Outperform | $204.35B | 45.73 | 7.92% | 1.43% | 25.91% | 74.58% | |
78 Outperform | $686.47B | 60.29 | 8.05% | ― | 34.97% | 123.87% | |
77 Outperform | $73.60B | 10.55 | 26.14% | 1.79% | 2.37% | 13.28% | |
74 Outperform | $275.51B | 28.56 | 32.49% | 3.11% | 14.89% | 10.49% | |
63 Neutral | $543.66B | -14.70 | -2.95% | ― | 1.36% | 86.07% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |